Loading…

Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis

To evaluate the demographics, genotype, and clinical presentation of pediatric patients presenting with distal intestinal obstruction syndrome (DIOS), and factors associated with DIOS recurrence. Case series of ten patients (median age 13.2 years), followed‐up in a reference center, retrospectively...

Full description

Saved in:
Bibliographic Details
Published in:Jornal de Pediatria (Versão em Português) 2020-11, Vol.96 (6), p.732-740
Main Authors: Sandy, Natascha S., Massabki, Lilian H.P., Gonçalves, Aline C., Ribeiro, Antonio F., Ribeiro, Jose D., Servidoni, Maria de Fátima C.P., Lomazi, Elizete A.
Format: Article
Language:Portuguese
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2097-b5e93fea6101151183c5f5c8a7df9771f0aaa377bbba98dc0df92af3489e7b793
container_end_page 740
container_issue 6
container_start_page 732
container_title Jornal de Pediatria (Versão em Português)
container_volume 96
creator Sandy, Natascha S.
Massabki, Lilian H.P.
Gonçalves, Aline C.
Ribeiro, Antonio F.
Ribeiro, Jose D.
Servidoni, Maria de Fátima C.P.
Lomazi, Elizete A.
description To evaluate the demographics, genotype, and clinical presentation of pediatric patients presenting with distal intestinal obstruction syndrome (DIOS), and factors associated with DIOS recurrence. Case series of ten patients (median age 13.2 years), followed‐up in a reference center, retrospectively assessed. Data analyzed included age, gender, cystic fibrosis genotype, meconium ileus at birth, hydration status, pulmonary exacerbation, Pseudomonas aeruginosa colonization, pancreatic insufficiency (PI), body mass index (BMI) at the episodes, clinical manifestations of DIOS, imaging studies performed, acute management of DIOS, maintenance therapy, and recurrence on follow‐up. All patients had two positive sweat chloride tests, and nine of ten also had genotype study. The most common genotype identified was homozygosis for the delta F508 mutation. In seven cases, a previous history of meconium ileus was reported. All patients had pancreatic insufficiency. Diagnosis of DIOS was based on clinical and imaging findings. Of the total number of episodes, 85% were successfully managed with oral osmotic laxatives and/or rectal therapy (glycerin enema or saline irrigation). Recurrence was observed in five of ten patients. In this first report of pediatric DIOS in South America, the presence of two risk factors for DIOS occurrence was universal: pancreatic insufficiency and severe genotype. Medical history of meconium ileus at birth was present in most patients, as well as in the subgroup with DIOS recurrence. The diagnosis relied mainly on the clinical presentation and on abdominal imaging. The practices in the management of episodes varied, likely reflecting changes in the management of this syndrome throughout time. Avaliar os dados demográficos, o genótipo e o quadro clínico de pacientes pediátricos que apresentam síndrome da obstrução intestinal distal (DIOS) e os fatores associados à recidiva da DIOS. Casuística de 10 pacientes (média de 13,2 anos) monitorados em um centro de referência e avaliados de forma retroativa. Os dados analisados incluíram idade, sexo, genótipo da fibrose cística, íleo meconial no nascimento, estado de hidratação, exacerbação pulmonar, colonização por Pseudomonas aeruginosa, insuficiência pancreática (IP), IMC nos episódios, manifestações clínicas da DIOS, estudos de diagnóstico por imagem realizados, manejo agudo da DIOS, terapia de manutenção e recidiva no acompanhamento. Todos os pacientes apresentaram dois exames de cloreto no suor po
doi_str_mv 10.1016/j.jpedp.2019.08.007
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_05b31bf62f3a46a89786734a44d5d66e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2255553619301740</els_id><doaj_id>oai_doaj_org_article_05b31bf62f3a46a89786734a44d5d66e</doaj_id><sourcerecordid>S2255553619301740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2097-b5e93fea6101151183c5f5c8a7df9771f0aaa377bbba98dc0df92af3489e7b793</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhgdRUKpP4GZeoGMymVxGcCH1Vii40XU4SU5qhnGmJFOhb2_airhydS6c_-P8f1FcU1JRQsVNV3UbdJuqJrStiKoIkSfFRV1zPuecidM__XlxlVJHCKkVF4rLiwIeQpqgL8MwYZrCkNvRpClu7RTGoUy7wcXxE29LKF2A9TDmI1vC4MrpAyNscLuf7Qf0PQ5rzJzS7g43Ppg4ppAuizMPfcKrnzor3p8e3xYv89Xr83Jxv5rbmrRybji2zCOI7IlyShWz3HOrQDrfSkk9AQAmpTEGWuUsyesaPGtUi9LIls2K5ZHrRuj0JoZPiDs9QtCHxRjXGmJ-rEdNuGHUeFF7Bo0A1UolJGugaRx3QmBmsSPLZgspov_lUaL3oetOH0LX-9A1UTqHnlV3RxVmm18Bo0424GDRhYh2yn-Ef_XfCg-Nbw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis</title><source>ScienceDirect Journals</source><creator>Sandy, Natascha S. ; Massabki, Lilian H.P. ; Gonçalves, Aline C. ; Ribeiro, Antonio F. ; Ribeiro, Jose D. ; Servidoni, Maria de Fátima C.P. ; Lomazi, Elizete A.</creator><creatorcontrib>Sandy, Natascha S. ; Massabki, Lilian H.P. ; Gonçalves, Aline C. ; Ribeiro, Antonio F. ; Ribeiro, Jose D. ; Servidoni, Maria de Fátima C.P. ; Lomazi, Elizete A.</creatorcontrib><description>To evaluate the demographics, genotype, and clinical presentation of pediatric patients presenting with distal intestinal obstruction syndrome (DIOS), and factors associated with DIOS recurrence. Case series of ten patients (median age 13.2 years), followed‐up in a reference center, retrospectively assessed. Data analyzed included age, gender, cystic fibrosis genotype, meconium ileus at birth, hydration status, pulmonary exacerbation, Pseudomonas aeruginosa colonization, pancreatic insufficiency (PI), body mass index (BMI) at the episodes, clinical manifestations of DIOS, imaging studies performed, acute management of DIOS, maintenance therapy, and recurrence on follow‐up. All patients had two positive sweat chloride tests, and nine of ten also had genotype study. The most common genotype identified was homozygosis for the delta F508 mutation. In seven cases, a previous history of meconium ileus was reported. All patients had pancreatic insufficiency. Diagnosis of DIOS was based on clinical and imaging findings. Of the total number of episodes, 85% were successfully managed with oral osmotic laxatives and/or rectal therapy (glycerin enema or saline irrigation). Recurrence was observed in five of ten patients. In this first report of pediatric DIOS in South America, the presence of two risk factors for DIOS occurrence was universal: pancreatic insufficiency and severe genotype. Medical history of meconium ileus at birth was present in most patients, as well as in the subgroup with DIOS recurrence. The diagnosis relied mainly on the clinical presentation and on abdominal imaging. The practices in the management of episodes varied, likely reflecting changes in the management of this syndrome throughout time. Avaliar os dados demográficos, o genótipo e o quadro clínico de pacientes pediátricos que apresentam síndrome da obstrução intestinal distal (DIOS) e os fatores associados à recidiva da DIOS. Casuística de 10 pacientes (média de 13,2 anos) monitorados em um centro de referência e avaliados de forma retroativa. Os dados analisados incluíram idade, sexo, genótipo da fibrose cística, íleo meconial no nascimento, estado de hidratação, exacerbação pulmonar, colonização por Pseudomonas aeruginosa, insuficiência pancreática (IP), IMC nos episódios, manifestações clínicas da DIOS, estudos de diagnóstico por imagem realizados, manejo agudo da DIOS, terapia de manutenção e recidiva no acompanhamento. Todos os pacientes apresentaram dois exames de cloreto no suor positivos e 09/10 também apresentaram estudo do genótipo. O genótipo mais comum identificado foi a homozigose da mutação delta F508. Em sete casos foi mencionado um histórico de íleo meconial. Todos os pacientes apresentaram insuficiência pancreática. O diagnóstico da DIOS teve como base achados clínicos e de imagem; 85% do número total de episódios foram tratados com sucesso com laxantes osmóticos orais e/ou terapia retal (enema de glicerina ou irrigação salina). A recidiva foi observada em 5 de 10 pacientes. Neste primeiro relatório da DIOS pediátrica na América do Sul, a presença de dois fatores de risco na ocorrência da DIOS foi universal: insuficiência pancreática e genótipo associado a doença grave. O histórico de íleo meconial no nascimento esteve presente na maioria dos pacientes, bem como no subgrupo com recidiva da DIOS. O diagnóstico dependeu principalmente do quadro clínico e do diagnóstico por imagem abdominal. As práticas de manejo de episódios variaram, provavelmente refletiram as mudanças no tratamento dessa síndrome ao longo do tempo.</description><identifier>ISSN: 2255-5536</identifier><identifier>EISSN: 2255-5536</identifier><identifier>DOI: 10.1016/j.jpedp.2019.08.007</identifier><language>por</language><publisher>Elsevier Editora Ltda</publisher><subject>Child ; Criança ; Cystic fibrosis ; Diagnosis ; Diagnóstico ; Fibrose cística ; Intestinal obstruction ; Obstrução intestinal ; Terapêutica ; Therapeutics</subject><ispartof>Jornal de Pediatria (Versão em Português), 2020-11, Vol.96 (6), p.732-740</ispartof><rights>2020 Sociedade Brasileira de Pediatria</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2097-b5e93fea6101151183c5f5c8a7df9771f0aaa377bbba98dc0df92af3489e7b793</cites><orcidid>0000-0002-2008-1747 ; 0000-0001-5504-4746 ; 0000-0002-3387-5642 ; 0000-0002-5549-8497 ; 0000-0002-9314-2563 ; 0000-0002-7744-8984 ; 0000-0002-5237-7227</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2255553619301740$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>Sandy, Natascha S.</creatorcontrib><creatorcontrib>Massabki, Lilian H.P.</creatorcontrib><creatorcontrib>Gonçalves, Aline C.</creatorcontrib><creatorcontrib>Ribeiro, Antonio F.</creatorcontrib><creatorcontrib>Ribeiro, Jose D.</creatorcontrib><creatorcontrib>Servidoni, Maria de Fátima C.P.</creatorcontrib><creatorcontrib>Lomazi, Elizete A.</creatorcontrib><title>Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis</title><title>Jornal de Pediatria (Versão em Português)</title><description>To evaluate the demographics, genotype, and clinical presentation of pediatric patients presenting with distal intestinal obstruction syndrome (DIOS), and factors associated with DIOS recurrence. Case series of ten patients (median age 13.2 years), followed‐up in a reference center, retrospectively assessed. Data analyzed included age, gender, cystic fibrosis genotype, meconium ileus at birth, hydration status, pulmonary exacerbation, Pseudomonas aeruginosa colonization, pancreatic insufficiency (PI), body mass index (BMI) at the episodes, clinical manifestations of DIOS, imaging studies performed, acute management of DIOS, maintenance therapy, and recurrence on follow‐up. All patients had two positive sweat chloride tests, and nine of ten also had genotype study. The most common genotype identified was homozygosis for the delta F508 mutation. In seven cases, a previous history of meconium ileus was reported. All patients had pancreatic insufficiency. Diagnosis of DIOS was based on clinical and imaging findings. Of the total number of episodes, 85% were successfully managed with oral osmotic laxatives and/or rectal therapy (glycerin enema or saline irrigation). Recurrence was observed in five of ten patients. In this first report of pediatric DIOS in South America, the presence of two risk factors for DIOS occurrence was universal: pancreatic insufficiency and severe genotype. Medical history of meconium ileus at birth was present in most patients, as well as in the subgroup with DIOS recurrence. The diagnosis relied mainly on the clinical presentation and on abdominal imaging. The practices in the management of episodes varied, likely reflecting changes in the management of this syndrome throughout time. Avaliar os dados demográficos, o genótipo e o quadro clínico de pacientes pediátricos que apresentam síndrome da obstrução intestinal distal (DIOS) e os fatores associados à recidiva da DIOS. Casuística de 10 pacientes (média de 13,2 anos) monitorados em um centro de referência e avaliados de forma retroativa. Os dados analisados incluíram idade, sexo, genótipo da fibrose cística, íleo meconial no nascimento, estado de hidratação, exacerbação pulmonar, colonização por Pseudomonas aeruginosa, insuficiência pancreática (IP), IMC nos episódios, manifestações clínicas da DIOS, estudos de diagnóstico por imagem realizados, manejo agudo da DIOS, terapia de manutenção e recidiva no acompanhamento. Todos os pacientes apresentaram dois exames de cloreto no suor positivos e 09/10 também apresentaram estudo do genótipo. O genótipo mais comum identificado foi a homozigose da mutação delta F508. Em sete casos foi mencionado um histórico de íleo meconial. Todos os pacientes apresentaram insuficiência pancreática. O diagnóstico da DIOS teve como base achados clínicos e de imagem; 85% do número total de episódios foram tratados com sucesso com laxantes osmóticos orais e/ou terapia retal (enema de glicerina ou irrigação salina). A recidiva foi observada em 5 de 10 pacientes. Neste primeiro relatório da DIOS pediátrica na América do Sul, a presença de dois fatores de risco na ocorrência da DIOS foi universal: insuficiência pancreática e genótipo associado a doença grave. O histórico de íleo meconial no nascimento esteve presente na maioria dos pacientes, bem como no subgrupo com recidiva da DIOS. O diagnóstico dependeu principalmente do quadro clínico e do diagnóstico por imagem abdominal. As práticas de manejo de episódios variaram, provavelmente refletiram as mudanças no tratamento dessa síndrome ao longo do tempo.</description><subject>Child</subject><subject>Criança</subject><subject>Cystic fibrosis</subject><subject>Diagnosis</subject><subject>Diagnóstico</subject><subject>Fibrose cística</subject><subject>Intestinal obstruction</subject><subject>Obstrução intestinal</subject><subject>Terapêutica</subject><subject>Therapeutics</subject><issn>2255-5536</issn><issn>2255-5536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kMtKAzEUhgdRUKpP4GZeoGMymVxGcCH1Vii40XU4SU5qhnGmJFOhb2_airhydS6c_-P8f1FcU1JRQsVNV3UbdJuqJrStiKoIkSfFRV1zPuecidM__XlxlVJHCKkVF4rLiwIeQpqgL8MwYZrCkNvRpClu7RTGoUy7wcXxE29LKF2A9TDmI1vC4MrpAyNscLuf7Qf0PQ5rzJzS7g43Ppg4ppAuizMPfcKrnzor3p8e3xYv89Xr83Jxv5rbmrRybji2zCOI7IlyShWz3HOrQDrfSkk9AQAmpTEGWuUsyesaPGtUi9LIls2K5ZHrRuj0JoZPiDs9QtCHxRjXGmJ-rEdNuGHUeFF7Bo0A1UolJGugaRx3QmBmsSPLZgspov_lUaL3oetOH0LX-9A1UTqHnlV3RxVmm18Bo0424GDRhYh2yn-Ef_XfCg-Nbw</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Sandy, Natascha S.</creator><creator>Massabki, Lilian H.P.</creator><creator>Gonçalves, Aline C.</creator><creator>Ribeiro, Antonio F.</creator><creator>Ribeiro, Jose D.</creator><creator>Servidoni, Maria de Fátima C.P.</creator><creator>Lomazi, Elizete A.</creator><general>Elsevier Editora Ltda</general><general>Brazilian Society of Pediatrics</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2008-1747</orcidid><orcidid>https://orcid.org/0000-0001-5504-4746</orcidid><orcidid>https://orcid.org/0000-0002-3387-5642</orcidid><orcidid>https://orcid.org/0000-0002-5549-8497</orcidid><orcidid>https://orcid.org/0000-0002-9314-2563</orcidid><orcidid>https://orcid.org/0000-0002-7744-8984</orcidid><orcidid>https://orcid.org/0000-0002-5237-7227</orcidid></search><sort><creationdate>202011</creationdate><title>Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis</title><author>Sandy, Natascha S. ; Massabki, Lilian H.P. ; Gonçalves, Aline C. ; Ribeiro, Antonio F. ; Ribeiro, Jose D. ; Servidoni, Maria de Fátima C.P. ; Lomazi, Elizete A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2097-b5e93fea6101151183c5f5c8a7df9771f0aaa377bbba98dc0df92af3489e7b793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2020</creationdate><topic>Child</topic><topic>Criança</topic><topic>Cystic fibrosis</topic><topic>Diagnosis</topic><topic>Diagnóstico</topic><topic>Fibrose cística</topic><topic>Intestinal obstruction</topic><topic>Obstrução intestinal</topic><topic>Terapêutica</topic><topic>Therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sandy, Natascha S.</creatorcontrib><creatorcontrib>Massabki, Lilian H.P.</creatorcontrib><creatorcontrib>Gonçalves, Aline C.</creatorcontrib><creatorcontrib>Ribeiro, Antonio F.</creatorcontrib><creatorcontrib>Ribeiro, Jose D.</creatorcontrib><creatorcontrib>Servidoni, Maria de Fátima C.P.</creatorcontrib><creatorcontrib>Lomazi, Elizete A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Jornal de Pediatria (Versão em Português)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sandy, Natascha S.</au><au>Massabki, Lilian H.P.</au><au>Gonçalves, Aline C.</au><au>Ribeiro, Antonio F.</au><au>Ribeiro, Jose D.</au><au>Servidoni, Maria de Fátima C.P.</au><au>Lomazi, Elizete A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis</atitle><jtitle>Jornal de Pediatria (Versão em Português)</jtitle><date>2020-11</date><risdate>2020</risdate><volume>96</volume><issue>6</issue><spage>732</spage><epage>740</epage><pages>732-740</pages><issn>2255-5536</issn><eissn>2255-5536</eissn><abstract>To evaluate the demographics, genotype, and clinical presentation of pediatric patients presenting with distal intestinal obstruction syndrome (DIOS), and factors associated with DIOS recurrence. Case series of ten patients (median age 13.2 years), followed‐up in a reference center, retrospectively assessed. Data analyzed included age, gender, cystic fibrosis genotype, meconium ileus at birth, hydration status, pulmonary exacerbation, Pseudomonas aeruginosa colonization, pancreatic insufficiency (PI), body mass index (BMI) at the episodes, clinical manifestations of DIOS, imaging studies performed, acute management of DIOS, maintenance therapy, and recurrence on follow‐up. All patients had two positive sweat chloride tests, and nine of ten also had genotype study. The most common genotype identified was homozygosis for the delta F508 mutation. In seven cases, a previous history of meconium ileus was reported. All patients had pancreatic insufficiency. Diagnosis of DIOS was based on clinical and imaging findings. Of the total number of episodes, 85% were successfully managed with oral osmotic laxatives and/or rectal therapy (glycerin enema or saline irrigation). Recurrence was observed in five of ten patients. In this first report of pediatric DIOS in South America, the presence of two risk factors for DIOS occurrence was universal: pancreatic insufficiency and severe genotype. Medical history of meconium ileus at birth was present in most patients, as well as in the subgroup with DIOS recurrence. The diagnosis relied mainly on the clinical presentation and on abdominal imaging. The practices in the management of episodes varied, likely reflecting changes in the management of this syndrome throughout time. Avaliar os dados demográficos, o genótipo e o quadro clínico de pacientes pediátricos que apresentam síndrome da obstrução intestinal distal (DIOS) e os fatores associados à recidiva da DIOS. Casuística de 10 pacientes (média de 13,2 anos) monitorados em um centro de referência e avaliados de forma retroativa. Os dados analisados incluíram idade, sexo, genótipo da fibrose cística, íleo meconial no nascimento, estado de hidratação, exacerbação pulmonar, colonização por Pseudomonas aeruginosa, insuficiência pancreática (IP), IMC nos episódios, manifestações clínicas da DIOS, estudos de diagnóstico por imagem realizados, manejo agudo da DIOS, terapia de manutenção e recidiva no acompanhamento. Todos os pacientes apresentaram dois exames de cloreto no suor positivos e 09/10 também apresentaram estudo do genótipo. O genótipo mais comum identificado foi a homozigose da mutação delta F508. Em sete casos foi mencionado um histórico de íleo meconial. Todos os pacientes apresentaram insuficiência pancreática. O diagnóstico da DIOS teve como base achados clínicos e de imagem; 85% do número total de episódios foram tratados com sucesso com laxantes osmóticos orais e/ou terapia retal (enema de glicerina ou irrigação salina). A recidiva foi observada em 5 de 10 pacientes. Neste primeiro relatório da DIOS pediátrica na América do Sul, a presença de dois fatores de risco na ocorrência da DIOS foi universal: insuficiência pancreática e genótipo associado a doença grave. O histórico de íleo meconial no nascimento esteve presente na maioria dos pacientes, bem como no subgrupo com recidiva da DIOS. O diagnóstico dependeu principalmente do quadro clínico e do diagnóstico por imagem abdominal. As práticas de manejo de episódios variaram, provavelmente refletiram as mudanças no tratamento dessa síndrome ao longo do tempo.</abstract><pub>Elsevier Editora Ltda</pub><doi>10.1016/j.jpedp.2019.08.007</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2008-1747</orcidid><orcidid>https://orcid.org/0000-0001-5504-4746</orcidid><orcidid>https://orcid.org/0000-0002-3387-5642</orcidid><orcidid>https://orcid.org/0000-0002-5549-8497</orcidid><orcidid>https://orcid.org/0000-0002-9314-2563</orcidid><orcidid>https://orcid.org/0000-0002-7744-8984</orcidid><orcidid>https://orcid.org/0000-0002-5237-7227</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2255-5536
ispartof Jornal de Pediatria (Versão em Português), 2020-11, Vol.96 (6), p.732-740
issn 2255-5536
2255-5536
language por
recordid cdi_doaj_primary_oai_doaj_org_article_05b31bf62f3a46a89786734a44d5d66e
source ScienceDirect Journals
subjects Child
Criança
Cystic fibrosis
Diagnosis
Diagnóstico
Fibrose cística
Intestinal obstruction
Obstrução intestinal
Terapêutica
Therapeutics
title Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distal%20intestinal%20obstruction%20syndrome:%20a%20diagnostic%20and%20therapeutic%20challenge%20in%20cystic%20fibrosis&rft.jtitle=Jornal%20de%20Pediatria%20(Versa%CC%83o%20em%20Portugue%CC%82s)&rft.au=Sandy,%20Natascha%20S.&rft.date=2020-11&rft.volume=96&rft.issue=6&rft.spage=732&rft.epage=740&rft.pages=732-740&rft.issn=2255-5536&rft.eissn=2255-5536&rft_id=info:doi/10.1016/j.jpedp.2019.08.007&rft_dat=%3Celsevier_doaj_%3ES2255553619301740%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2097-b5e93fea6101151183c5f5c8a7df9771f0aaa377bbba98dc0df92af3489e7b793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true